Financial News
Corvus Pharma Com (NQ: CRVS )
2.880
USD
-0.030
(-1.03%)
Official Closing Price
Updated: 7:53 PM EST, Mar 5, 2021
Add to My Watchlist
All news about Corvus Pharma Com
The Week Ahead In Biotech: Supernus, Sanofi Await FDA Decisions
November 08, 2020
From Benzinga
Week In Review: $1.5 Billion Total In Week's China Deals
October 10, 2020
From Blogs - TalkMarkets
Week in Review: $1.5 Billion Total in Week's China Deals
October 10, 2020
From ChinaBio® Today
58 Biggest Movers From Yesterday
October 07, 2020
From Benzinga
10 Biggest Price Target Changes For Tuesday
October 06, 2020
From Benzinga
62 Biggest Movers From Yesterday
October 06, 2020
From Benzinga
Mid-Afternoon Market Update: Dow Surges 350 Points; Eidos Therapeutics Shares Spike Higher
October 05, 2020
From Benzinga
12 Healthcare Stocks Moving In Monday's Intraday Session
October 05, 2020
From Benzinga
From Benzinga
50 Stocks Moving In Monday's Mid-Day Session
October 05, 2020
From Benzinga
Why Corvus Pharmaceuticals Is Trading Higher Today
October 05, 2020
From Benzinga
Looking Into Corvus Pharmaceuticals's Return On Capital Employed
October 05, 2020
From Benzinga
Thinking about buying stock in Enlivex Therapeutics, Corvus Pharmaceuticals, Livent Corp, Solid Biosciences, or Boxlight Corp?
October 05, 2020
From PR Newswire
What Are The Best Penny Stocks To Buy Now? 5 Moving Premarket
October 05, 2020
12 Healthcare Stocks Moving In Monday's Pre-Market Session
October 05, 2020
From Benzinga
From ChinaBio® Today
Corvus Pharmaceuticals Appoints Edith Mitchell, M.D., to Board of Directors
September 11, 2020
61 Biggest Movers From Yesterday
September 11, 2020
From Benzinga
Corvus Announces Participation in Upcoming Investor Conferences
September 08, 2020
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.